UK Clinical Trial Imaging Market Size & Outlook, 2024-2030

The clinical trial imaging market in UK is expected to reach a projected revenue of US$ 81.6 million by 2030. A compound annual growth rate of 8.5% is expected of UK clinical trial imaging market from 2025 to 2030.
Revenue, 2024 (US$M)
$50.2
Forecast, 2030 (US$M)
$81.6
CAGR, 2025 - 2030
8.5%
Report Coverage
UK

UK clinical trial imaging market highlights

  • The UK clinical trial imaging market generated a revenue of USD 86.4 million in 2023 and is expected to reach USD 149.8 million by 2030.
  • The UK market is expected to grow at a CAGR of 8.2% from 2024 to 2030.
  • In terms of segment, project and data management was the largest revenue generating service in 2023.
  • System and Technology Support Services is the most lucrative service segment registering the fastest growth during the forecast period.


Clinical trial imaging market data book summary

Market revenue in 2023USD 86.4 million
Market revenue in 2030USD 149.8 million
Growth rate8.2% (CAGR from 2023 to 2030)
Largest segmentProject and data management
Fastest growing segmentSystem and Technology Support Services
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationClinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management
Key market players worldwideIxico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health


Other key industry trends

  • In terms of revenue, UK accounted for 7.6% of the global clinical trial imaging market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK clinical trial imaging market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 132.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Imaging Market Scope

Clinical trial imaging market segmentation & scope
Countries
UK
UAE
Mexico
Sweden
Denmark
Norway
Australia
Kuwait

Clinical Trial Imaging Market Companies

Name Profile # Employees HQ Website

UK clinical trial imaging market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.


Project and data management was the largest segment with a revenue share of 28.7% in 2024. Horizon Databook has segmented the UK clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.


In the UK, there is rising prevalence of diseases such as cancer, cardiovascular, dementia, and others. Cancer accounted for 31% and 26% of the deaths in men and women, respectively. It is the leading cause of death, followed by Alzheimer’s and other dementias.

In the UK, clinical trials are currently regulated by the EU Clinical Trials Directive that was altered into the UK law in 2004. The directive has been criticized for increasing the cost of running trials and bureaucratic burden in the EU.

Later in 2014, a novel EU Clinical Trial Regulation was established to address these problems. It includes a new EU-wide portal along with a database, offering a single point of entry for all applications of the clinical trials in the EU.

Reasons to subscribe to UK clinical trial imaging market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK clinical trial imaging market databook

  • Our clientele includes a mix of clinical trial imaging market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into UK clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK clinical trial imaging market size, by modality, 2018-2030 (US$M)

UK Clinical Trial Imaging Market Outlook Share, 2024 & 2030 (US$M)

UK clinical trial imaging market size, by modality, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more